ArticleJournal of ophthalmology2020

Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization.

Xiaoli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.